Yuichiro Ohe

Prospective Evaluation of the Feasibility of Cisplatin‐based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions

Fumihiro Oshita, Takayasu Kurata, Takashi Kasai et al. · Japanese Journal of Cancer Research · 1995 · 81 citations · Full text

Medicine, Geriatric Medicine, Oncology +15

Amivantamab and lazertinib in patients with EGFR-mutant non–small cell lung (NSCLC) after progression on osimertinib and platinum-based chemotherapy: Updated results from CHRYSALIS-2.

Catherine A. Shu, Kōichi Goto, Yuichiro Ohe et al. · Journal of Clinical Oncology · 2022 · 60 citations

Medicine, Oncology, Pharmacology +14

Combination effect of vaccination with IL2 and IL4 cdna transfected cells on the induction of a therapeutic immune response against lewis lung carcinoma cells

Yuichiro Ohe, Eckhard R. Podack, Kristin J. Olsen et al. · International Journal of Cancer · 1993 · 42 citations

Medicine, Immunology, Oncology +17

Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial

Yoshimasa Shiraishi, Shogo Nomura, Shunichi Sugawara et al. · The Lancet Respiratory Medicine · 2024 · 39 citations

Medicine, Oncology, Pharmacology +17

Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A

Benjamin Besse, Kōichi Goto, Yongsheng Wang et al. · Journal of Thoracic Oncology · 2025 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15